Abstract
This article examines the importance of information giving and its role in gaining informed consent from patients with sickle cell disease requiring exchange blood transfusion for the management of stroke. The rationale for the use of exchange blood transfusion in patients with sickle cell disease who have had a stroke is explained. The impact of stroke on cognition is highlighted and the implications for informed decision making are considered. Other factors such as communicating risk are discussed.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
